Blog - Page 1472 of 5721

ThursdayMar 18, 2021 9:50 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Receives European Approval for 25 Minute COVID-19 PCR Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT),a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, along with its German diagnostics development partner, 3a-diagnostics GmbH ("3a"), has received European approval of its point-of-care SARS-CoV-2 RT-PCR test system, called Covid-ID Lab. Covid-ID Lab is now registered as a commercial in vitro diagnostic (CE-IVD) test in Europe, and plans are in place to launch the product in Europe in April 2021. XPhyto is exploring options with various potential distribution and wholesale partners as well as potential licensees. The test offers high sensitivity, high specificity, and high robustness,…

WednesdayMar 17, 2021 3:08 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Takes Milestone Step Toward Offering Product Across Canada

PULL subsidiary has submitted application to Health Canada to amend license to permit sales of product The submission follows recent announcement that Pure Extracts inked distribution agreement with an important Canadian Licensed Producer (“LP”) PULL plans on distributing exclusive vape, edible products to retail buyers across Canada As a result of the its recently inked distribution agreement with an important Canadian LP, Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) through its wholly owned subsidiary, Pure Extracts Manufacturing Corp., will be selling its exclusive, high-quality cannabis extract products to provincially authorized distributors and retailers throughout Canada by the end of April.…

WednesdayMar 17, 2021 2:56 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces Filing of Reg A with the SEC

Healthtech Solutions (OTC: HLTT), parent company of Medi-Scan Inc. and RevHeart Inc., today announced that it filed a Reg A with the Securities and Exchange Commission on Monday, March 8, 2021, to raise up to $75 million. According to the update, the company is offering up to a maximum of 1,500,000 shares of Series B preferred stock, $0.001 par value (“Preferred Stock”), at an offering price of $50 per share. The price will remain fixed for the duration of the Offering (the “Offered Shares”). The Offering will enable Healthtech Solutions to implement its three-pronged growth plan, which includes: the creation…

WednesdayMar 17, 2021 2:48 pm

Uranium Energy Corp. (NYSE American: UEC) Chairman and Former U.S. Energy Secretary: A Renaissance Coming for Nuclear Energy Under New Administration

Currently, nuclear power is the nation’s 2nd largest source of electricity production, providing 20% of the nations’ total generation As a result of its carbon-free, emission free attributes, nuclear power is likely to grow with the new Administration’s clean energy initiatives, including those supporting a transition to more EV’s Nuclear energy is America’s largest source of carbon-free energy and its largest source of baseload power that isn’t a fossil fuel source UEC has a near-term production profile of 4 million pounds U3O8 per year via its low cost, environmentally friendly In-Situ Recovery (“ISR”) projects in Texas and Wyoming With every…

WednesdayMar 17, 2021 2:31 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Announces Completion of Uranium Purchases, Additional Funding

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has secured 800,000 pounds of additional U.S.-warehoused uranium; the shipment is comprised of a delivery in April consisting of 500,000 pounds and a second delivery scheduled for December consisting of 300,000 pounds; this uranium purchase follows a previously announced acquisition of 400,000 pounds. In total, UEC now has contracts to purchase 1,200,000 pounds of U3O8 at a volume-weighted average price of $28.94 per pound. In addition, the company has entered into definitive agreements with institutional investors to purchase 10,000,000 UEC common shares at $3.05 per share. The registered direct offering, which…

WednesdayMar 17, 2021 2:00 pm

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

Imagin Medical is a surgical company focused on developing its i/Blue(TM) Imaging System, employing patented ultrasensitive imaging technology The i/Blue(TM) Imaging System is system compatible; system attaches to most endoscopes The company recently closed the second tranche for the amount of US$1,415,500 of the Convertible Note offering Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive surgical procedures. Imagin Medical is run by an experienced management team that is preparing their i/Blue(TM) Imaging System for the industry. An FDA approval process is underway. The company’s patented ultrasensitive…

WednesdayMar 17, 2021 1:40 pm

Green Hygienics Holdings Inc. (GRYN) Continues to Strengthen Brand Portfolio through Acquisition of Primordia

GRYN closes acquisition of assets of leading hemp supply cultivation and company Primordia “We are at the forefront of a growing, dynamic new sector within the biotech industry,” says CEO Green Hygienics focused on building strong portfolio in industry expected to reach $15.26 billion by 2027 Green Hygienics Holdings (OTCQB: GRYN) has been working for months to reach an objective — a goal that the company accomplished with the recent announcement that it had closed on the acquisition of certain assets of Primordia (https://ibn.fm/QTc62). This strategic move brings GRYN a significant step closer to its goal of building a portfolio of…

WednesdayMar 17, 2021 1:22 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Sites for Phase 2B Clinical Trial

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient’s survival and/or quality of life, today announced that it has selected five U.S. clinical sites to enroll patients with ulcerative necrobiosis lipoidica for the company’s Phase 2B trial. In addition, two to three more clinical sites will be selected for the trial, “A Randomized, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients who Have Necrobiosis Lipoidica.” “We have selected five U.S. sites to evaluate this…

WednesdayMar 17, 2021 1:03 pm

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Enters Strategic Commercial Agreement

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., has signed a commercial cooperation agreement with SaverOne 2014 Ltd. (TASE: SAVR), a leader in providing an effective solution to combat cell phone distracted driving. According to the update, Eye-Net will integrate its Eye-Net(TM) Protect solution in SaverOne’s product designed to prevent the use of texting applications by the driver while the vehicle is in motion. The integration is subject to certain tests and criteria to be determined by the parties. “Eye-Net is expanding its presence in…

WednesdayMar 17, 2021 12:46 pm

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Targets the European and Canadian Markets

InsuraGuest Technologies is a leading insurtech (insurance + technology) company that offers Hospitality Liability coverage for the hotel and vacation rental markets, utilizing its proprietary software platform The company is looking to enter the European and Canadian markets in 2021, according to their latest press release The two markets offer promise, given the size of the SMEs and projections on revenue generated from the traditional hospitality sector and vacation/holiday rental homes InsuraGuest already has existing insurance partnerships with leading underwriting companies, and distribution with leading insurance agencies The world of insurance is experiencing a shakeup thanks to technology. At the…

Site Search

Company Search